ROG
Rogers Corp.

457
Mkt Cap
$1.39B
Volume
99,783.00
52W High
$111.39
52W Low
$51.43
PE Ratio
-21.26
ROG Fundamentals
Price
$75.56
Prev Close
$77.11
Open
$78.82
50D MA
$82.92
Beta
1.15
Avg. Volume
183,055.22
EPS (Annual)
$1.40
P/B
1.15
Rev/Employee
$259,406.25
Loading...
Loading...
News
all
press releases
Bank of Montreal Can Purchases New Position in Rogers Corporation $ROG
Bank of Montreal Can bought a new position in shares of Rogers Corporation (NYSE:ROG - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·15h ago
News Placeholder
More News
News Placeholder
Nuance Investments LLC Has $27.64 Million Stock Holdings in Rogers Corporation $ROG
Nuance Investments LLC trimmed its stake in shares of Rogers Corporation (NYSE:ROG - Free Report) by 34.6% in the second quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·10d ago
News Placeholder
Rogers Corp. (ROG) Q3 Earnings and Revenues Surpass Estimates
Rogers Corp. (ROG) delivered earnings and revenue surprises of +28.57% and +4.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
News Placeholder
Rogers Corporation Reports Third Quarter 2025 Results
Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter of 2025. 'Third quarter results were at the upper end of guidance due to improved end-market demand and good...
Business Wire·22d ago
News Placeholder
Rogers Corporation Announces Transition of Board Chair and Plans to Add New Independent Director
Rogers Corporation (NYSE: ROG) (the Company) today announced that Peter Wallace, Chair of the Board of Directors (the Board), has informed the Board of his decision not to stand for re-election at...
Business Wire·1mo ago
News Placeholder
Rogers Corporation Schedules Third Quarter 2025 Earnings Call for October 29
Rogers Corporation (NYSE:ROG) (Rogers) plans to announce third quarter 2025 results on October 29, 2025 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be...
Business Wire·1mo ago
News Placeholder
Roche's Elecsys pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
Roche's Elecsys pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology Roche's Elecsys pTau181 becomes the only FDA-cleared blood...
PR Newswire·1mo ago
News Placeholder
Strength Seen in Ouster (OUST): Can Its 13.4% Jump Turn into More Strength?
Ouster (OUST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·2mo ago
News Placeholder
Rogers Corp. (ROG) Q2 Earnings Lag Estimates
Rogers Corp. (ROG) delivered earnings and revenue surprises of -32.00% and +2.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Sarepta stock falls after Elevidys fails to get backing by EU regulators
Investing.com -- Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock declined 13% Friday after European regulators recommended against approving Elevidys, the company’s gene therapy for Duchenne muscular dystrophy.
investing.com·4mo ago

Latest ROG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.